1. Chromatin Remodeling During Leukemia Cell Proliferation and Differentiation
   Rūta Navakauskienė et al, 2021, Epigenetics and Proteomics of Leukemia CrossRef
2. Antitumor Effects of Saffron-Derived Carotenoids in Prostate Cancer Cell Models
   Claudio Festuccia et al, 2014, BioMed Research International CrossRef
3. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258
   Stefan Vallo et al, 2013, Investigational New Drugs CrossRef
4. Research progress and applications of epigenetic biomarkers in cancer
   Jianjun Gao et al, 2024, Frontiers in Pharmacology CrossRef
5. Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
   Robert Jenke et al, 2021, Cancers CrossRef
6. Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma
   Alessandro Colapietro et al, 2021, Pharmaceuticals CrossRef
7. Proteome in Leukemic vs. Differentiated Leukemia Cells
   Rūta Navakauskienė et al, 2021, Epigenetics and Proteomics of Leukemia CrossRef